On behalf of Vertex Pharmaceuticals, you are warmly invited to attend the next webinar in the C FURTHER meeting series. This series aims to provide an update on the latest data in CFTR modulator therapies and act as a forum for sharing clinical experience. The second webinar of this year will discuss monitoring and managing lung disease in patients with cystic fibrosis who are treated with a CFTR modulator.

MDT management of patients with cystic fibrosis treated with a CFTR modulator

Speakers: Dr Uroš Krivec, Dr Jernej Brecelj and Majda Oštir
Date: Thursday, 21 October 2021
Time: 15:00 - 15:50 CET
I confirm that I am a healthcare professional according to local law and codes - Required
By clicking this button, you submit your information to the webinar organiser, who will use it to communicate with you regarding this event.
I agree to receive marketing e-mails and other promotional communications…read more
Please note that the webinar will be recorded
Watch Teaser Video

For more information about the meeting please refer to your meeting invitation or contact your local Medison representative. Medison is the acting distributor company in CEE markets on behalf of Vertex Pharmaceuticals.

Licensed Vertex medicines will be discussed at this meeting. Prescribing Information will be available at this meeting. This meeting is organised and fully funded by Vertex. This meeting is for Healthcare Professionals in Bulgaria, Czech Republic, Croatia, Hungary, Romania, Slovenia and Poland.